Andrea S. James Oncocyte Corp (OCX) insider trading activity

OCX Quotes by TradingView

Andrea S. James is Chief Financial Officer of Oncocyte Corp. Currently has a direct ownership of 201,231 shares of OCX, which is worth approximately $571,496. The most recent transaction as insider was on Oct 31, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 201K
33.06% 3M change
497.66% 12M change
Total Value Held $571,496

Andrea S. James Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 31 2025
BUY
Exercise of conversion of derivative security
-
50,000 Added 19.9%
201,231 Common Stock
Feb 07 2025
BUY
Open market or private purchase
$200,000 $2.05 p/Share
97,561 Added 39.21%
151,231 Common Stock, No Par V...
Dec 05 2024
BUY
Open market or private purchase
$45,800 $2.29 p/Share
20,000 Added 27.15%
53,670 Common Stock, No Par V...
Oct 02 2024
BUY
Open market or private purchase
$99,999 $2.97 p/Share
33,670 Added 50.0%
33,670 Common Stock, No Par V...
ASJ

Andrea S. James

Chief Financial Officer
Irvine, CA

Track Institutional and Insider Activities on OCX

Follow Oncocyte Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

News

Receive news related to Oncocyte Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCX